as 701

AS-701 is a Li+ selective ionophore in the therapy of manic-depressive illness.

Tempol (Tanol) is a superoxide scavenger. It has anti-inflammatory, neuroprotective and analgesic effects.

RES-701-1 is a cyclic peptide consisting of 16 common L-amino acids. It acts as a specific antagonist of the ETB receptor. RES-701-1 inhibits the binding of 125I-ET-1 (125I-labeled endothelin (ET)-1) to the ETB receptor, with an IC50 value of 10 nM.

RK-701, a highly selective and non-genotoxic G9a inhibitor, exhibits an IC 50 value of 23-27 nM. It selectively up-regulates HbF, γ-Globin, and BGLT3 expression while down-regulating H3K9me2 expression. Additionally, RK-701 inhibits BCL11A and ZBTB7A.

Anti-HGF/SF Antibody (TAK-701) is a CHO-expressed human antibody targeting HGF/SF. It features a huIgG1 heavy chain and a huκ light chain, with a predicted molecular weight (MW) of 153.8 kDa. For isotype control, please refer to Human IgG1 kappa, Isotype Control.

The compound M701 is a bispecific antibody that targets CD3 on T cells and EpCAM on tumor cells, aiming to stimulate T cell-mediated tumor cell death. It is being developed for the treatment of malignant ascites by redirecting T cells to attack tumors expressing EpCAM. [Molecular weight: 125.84 kDa]

Compound Fr12214, with CAS No. 701-43-9, is a fragment molecule that serves as an important scaffold for molecular linking, expansion, and modification. Compound Fr12214 provides a structural basis and research tool for the design and screening of novel drug candidates, and is commonly used in drug discovery, drug synthesis, and related research.

GLP-1 receptor agonist 17-d3 (Compound 701) is the deuterated form of GLP-1R agonist 17, which acts as a GLP-1 receptor agonist and is applicable in cardiovascular and metabolic disease research.